Compare ARK Genomic Revolution ETF (ARKG) vs JPMorgan Equity Premium Income ETF (JEPI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs JPMorgan Equity Premium Income ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.21, while JPMorgan Equity Premium Income ETF trades at $56.76. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, JPMorgan Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | JEPI | |
|---|---|---|
Sector | Sector/Thematic | Income / Options Overlay |
52-Week High | $43.57 | $59.88 |
52-Week Low | $23.09 | $55.29 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
JEPI trades at $56.76, up 0.23% with a bullish technical signal from moving averages. The ETF's covered-call strategy generates an 8%+ yield but caps upside potential during bull markets. Recent news highlights JEPI's appeal for income-focused investors seeking monthly distributions with lower volatility than the S&P 500.
JEPI offers high income through option premiums but faces total return limitations in rising markets. The fund's active management provides drawdown resilience, though tax efficiency concerns exist compared to alternatives. Current market conditions favor income strategies, but investors should weigh yield against growth constraints.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About JPMorgan Equity Premium Income ETF
JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →
